Table 4.

Attitudes towards choice of antipsychotics for patients with schizophrenia – mean scores

Means statements, oral versus LAI	All	The Netherlands	Belgium	Germany	Italy	UK	France	Nordic countries
	N = 891	n = 109	n = 97	n = 182	n = 187	n = 83	n = 132	n = 101
1. If a patient is on a LAI antipsychotic and did not appear at the administration appointment as prescribed I can act upon it	5.4	5.6	5.1	5.6	5.8	5.6	4.6	5.7
2. If a patient is on oral antipsychotics, it is impossible to ascertain whether the patient has been taking an antipsychotic or not	4.3	4.4	4.9	3.3	4.7	4.1	4.5	4.2
3. Because of adherence advantages of LAIs, a lower rate of relapse can be ensured	5.5	5.4	5.5	5.7	5.6	5.2	5.5	5.2
4. The best way of managing non-adherence with antipsychotics (due to poor insight) is with LAIs	5.2	5.1	5.2	5.4	5.4	5.2	4.8	5.0
5. Administration of a LAI antipsychotic in the deltoid muscle as opposed to the buttocks is a respectful way of administering antipsychotics	4.6	4.7	4.6	4.4	4.4	5.2	4.7	5.0
6. The ability to administer a LAI antipsychotic in the deltoid muscle instead of the gluteal muscle will lead to an increase in the use of LAI antipsychotic medication	4.2	4.1	4.3	4.0	4.1	4.4	4.2	4.7
7. Current oral antipsychotics can get many patients well, but LAI atypical antipsychotics will keep the patients well	4.6	4.7	5.0	3.8	5.0	4.8	5.0	4.5

Respondents (Base: total n = 891) were asked to indicate, on a scale ranging from one to seven, whether they agreed or disagreed (1 = strongly disagree, 7 = strongly agree) with statements comparing long-acting medication with oral medication (question numbers 1–4 and 7) and statements comparing deltoid administration with oral administration (question numbers 5 and 6).